Portola has been acquired by Alexion Pharmaceuticals, Inc.

Logo for Alexion a global biopharmaceutical focused on serving patients affected with rare diseases

Portola has been acquired by Alexion Pharmaceuticals, Inc.

Learn More

  • For US Healthcare Professionals

Request Support

Our experienced reimbursement team is ready to answer your questions and guide you through the coding, billing and payment process. Simply complete the information below and we’ll be in touch soon.

You can also contact us by phone at: 1-866-263-3992 or Email us at: [email protected]

* indicates required field




×

You are about to leave PortolaAccess.com

By clicking “Continue” below, you will transfer to another Portola website. Please note that the privacy policy and security practices may differ from those of the Portola Access site.

To stay on the current website, click "Cancel." Click "Continue" if you wish to continue on to the website you clicked on.

Continue Cancel